Lenalidomide as induction therapy before allogeneic stem cell transplantation in a patient with proliferative CMML-2 and del(5q) not involving the EGR1 locus. [electronic resource]
Producer: 20071211Description: 2384-5 p. digitalISSN:- 0887-6924
- Aged
- Antineoplastic Agents -- therapeutic use
- Cell Proliferation
- Chromosomes, Human, Pair 5
- Cytogenetics
- Early Growth Response Protein 1 -- genetics
- Gene Deletion
- Humans
- Lenalidomide
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive -- genetics
- Male
- Remission Induction
- Stem Cell Transplantation -- methods
- Thalidomide -- analogs & derivatives
- Time Factors
- Transplantation, Homologous -- methods
No physical items for this record
Publication Type: Letter
There are no comments on this title.
Log in to your account to post a comment.